Recently, an increasing number of studies have reported that Capn4 expression was upregulated in cancer tissues and there were correlations between Capn4 level and clinical outcomes in multiple malignancies, such as colorectal, esophageal, and ovarian cancer [9–11]. Here, CAPNS1 is linked to ovarian carcinoma.